Jump Trading’s Solid Biosciences SLDB Stock Holding History

Jump Trading’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,333	Closed	-$184K	–	550
2019 Q1	$184K	Buy	+1,333	New	+$334K	0.06%	399

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jump Trading's SLDB Position: Q2 2019 in Review

Jump Trading sold out of Solid Biosciences (SLDB) in Q2 2019, closing a stake of 1,333 shares — an estimated $184K sold.

Jump Trading first reported a position in SLDB in Q1 2019 and held it in 1 quarter. The position peaked at $184K in Q1 2019. 74 funds tracked by Wall St. Rank hold SLDB as of Q2 2019.

Jump Trading reported no remaining Solid Biosciences position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 1,333 Solid Biosciences shares in Q2 2019, an estimated $184K.
Jump Trading first reported a position in Solid Biosciences in Q1 2019 and held it in 1 quarter.
Jump Trading's Solid Biosciences position peaked at $184K in Q1 2019.
74 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.